|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 4.980 CNY | +2.89% |
|
+2.05% | -9.95% |
EPS & Dividend: North China Pharmaceutical Company.Ltd
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.03 | 0.06 | - | 0.01 | 0.03 | 0.035 |
| Rate of return | 0.29% | 0.5% | - | 0.18% | 0.58% | 0.63% |
| EPS 2 | 0.06 | 0.011 | -0.402 | 0.003 | 0.074 | 0.107 |
| Distribution rate | 50% | 545% | - | 333% | 40.5% | 32.7% |
| Reference price 2 | 10.290 | 11.920 | 6.400 | 5.700 | 5.170 | 5.530 |
| Nbr of stocks (in thousands) | 1,630,805 | 1,715,730 | 1,715,730 | 1,715,730 | 1,715,730 | 1,715,730 |
| Announcement Date | 4/28/21 | 4/27/22 | 4/21/23 | 3/29/24 | 3/27/25 | 4/17/26 |
1CNY in Million2CNY
Estimates
Past dividends: North China Pharmaceutical Company.Ltd
| 2026-06-11 | Ex-dividend date - 0.035 CNY | 00:00 |
Upcoming Events: North China Pharmaceutical Company.Ltd
| 2026-10-28 | Earnings release | Q3 2026 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.6% | 0.67% | 32.69x | 20.77x | 11.85x | |
| 2.06% | 2.15% | 28.77x | 7.22x | 6.4x | |
| 2.67% | 2.77% | 32.89x | -473.35x | 7.71x | |
| 2.37% | 2.47% | 104.62x | 7.32x | 5.85x | |
| 2.87% | 2.94% | 18.99x | 6.94x | 4.63x | |
| 3.06% | 3.19% | 20.13x | 5.71x | 5.23x | |
| 2.1% | 2.23% | 20.27x | 4.57x | 4.21x | |
| 2.48% | 2.62% | 25.72x | 19.46x | 6.72x | |
| 2.23% | 2.27% | -44.61x | 10.98x | 6.5x | |
| Average | 2.27% | 2.37% | 26.61x | -43.38x | 6.57x | |
| Weighted average by Cap. | 1.95% | 2.04% | 31.73x | -47.80x | 7.64x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
